Importance of Calcium Co-Medication in Bisphosphonate Therapy of Osteoporosis
- 1 January 2006
- journal article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 23 (7), 569-578
- https://doi.org/10.2165/00002512-200623070-00003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Energy and nutrient intake of young-old, old-old and very-old elderly in GermanyEuropean Journal of Clinical Nutrition, 2004
- Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliancePublished by Oxford University Press (OUP) ,2001
- Self-administration of medicine and older peopleNursing Standard, 2001
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Correcting calcium nutritional deficiency prevents spine fractures in elderly womenJournal of Bone and Mineral Research, 1996
- Bisphosphonates: A review of their pharmacokinetic propertiesBone, 1996
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain.BMJ, 1988
- DIETARY CALCIUM AND RISK OF HIP FRACTURE: 14-YEAR PROSPECTIVE POPULATION STUDYThe Lancet, 1988